GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » CareCloud Inc (NAS:CCLD) » Definitions » ROE % Adjusted to Book Value

CCLD (CareCloud) ROE % Adjusted to Book Value : 30.25% (As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is CareCloud ROE % Adjusted to Book Value?

CareCloud's ROE % for the quarter that ended in Sep. 2024 was 27.83%. CareCloud's PB Ratio for the quarter that ended in Sep. 2024 was 0.92. CareCloud's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was 30.25%.


CareCloud ROE % Adjusted to Book Value Historical Data

The historical data trend for CareCloud's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CareCloud ROE % Adjusted to Book Value Chart

CareCloud Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.84 -10.19 2.97 12.95 -117.03

CareCloud Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -57.67 -464.05 -5.16 21.97 30.25

Competitive Comparison of CareCloud's ROE % Adjusted to Book Value

For the Health Information Services subindustry, CareCloud's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CareCloud's ROE % Adjusted to Book Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, CareCloud's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where CareCloud's ROE % Adjusted to Book Value falls into.



CareCloud ROE % Adjusted to Book Value Calculation

CareCloud's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-67.88% / 0.58
=-117.03%

CareCloud's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=27.83% / 0.92
=30.25%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CareCloud ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of CareCloud's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


CareCloud Business Description

Traded in Other Exchanges
Address
7 Clyde Road, Somerset, NJ, USA, 08873
CareCloud Inc is a healthcare information technology company. It provides a full suite of proprietary cloud-based solutions and related business services. Its Software-as-a-Service platforms include practice management (PM), electronic health record (EHR), business intelligence, telehealth, patient experience management (PXM) solutions, and robotic processing automation (RPA) bots, along with complementary software tools and business services such as revenue cycle management (RCM), premiere healthcare consulting and implementation services, and on-demand workforce staffing capabilities for high-performance medical groups and health systems nationwide. The operating segments of the group are Healthcare IT, which is the key revenue generating segment, and Practice Management.
Executives
John N Daly director 390 STANWICH ROAD, GREENWICH CT 06830
Mahmud Ul Haq director, 10 percent owner, officer: Chief Executive Officer 7 CLYDE ROAD, SOMERSET NJ 08873
Lawrence Steven Sharnak director 7393, ORANGEWOOD LANE, BOCA RATON FL 33433
Anne Busquet director 390 PARK AVE 4TH FLR, NEW YORK NY 10022
A Hadi Chaudhry officer: President 7 CLYDE ROAD, SOMERSET NJ 08873
Nathalie Grey Garcia officer: General Counsel & Secretary 7 CLYDE ROAD, SOMERSET NJ 08873
Lawrence J. Steenvoorden officer: Chief Financial Officer C/O CHEMBIO DIAGNOSTICS, INC., 555 WIRELESS BOULEVARD, HAUPPAUGE NY 11788
Stephen Andrew Snyder director, officer: President 7 CLYDE ROAD, SOMERSET NJ 08873
Bill Korn officer: Chief Financial Officer 61 DARREN DRIVE, BASKING RIDGE NJ 07920
Kimberly J Grant officer: General Counsel & Secretary 7 CLYDE ROAD, SOMERSET NJ 08873
Cameron Munter director 295 WEST ORANGE GROVE AVE, SIERRA MADRE CA 91024
Shruti H Patel officer: Interim Corporate Secretary 7 CLYDE ROAD, SOMERSET NJ 08873
Amritpal K. Deol officer: See Remarks 7 CLYDE ROAD, SOMERSET NJ 08873
Norman Roth officer: See Remarks 7 CLYDE ROAD, SOMERSET NJ 08873
Brendan Patrick Harney officer: See Remarks 7 CLYDE ROAD, SOMERSET NJ 08873